Cargando…
Validation of B·R·A·H·M·S PCT direct, a new sensitive point-of-care testing device for rapid quantification of procalcitonin in emergency department patients: a prospective multinational trial
Autores principales: | Kutz, A, Hausfater, P, Oppert, M, Alonso, C, Wissmann, C, Mueller, B, Schuetz, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470933/ http://dx.doi.org/10.1186/cc14136 |
Ejemplares similares
-
A new sensitive automated assay for procalcitonin detection: LIAISON(®) BRAHMS PCT(®) II GEN
por: Fortunato, Antonio
Publicado: (2016) -
Procalcitonin (PCT)
por: Horns, Heidi, et al.
Publicado: (2021) -
Analytical evaluation of the novel Lumipulse G BRAHMS procalcitonin immunoassay
por: Ruzzenente, Orazio, et al.
Publicado: (2016) -
Combination of the National Early Warning Score (NEWS) and inflammatory biomarkers for early risk stratification in emergency department patients: results of a multinational, observational study
por: Eckart, Andreas, et al.
Publicado: (2019) -
Brahms
por: Rémy, Yves y Ada
Publicado: (1981)